Engineering proteins often requires introducing multiple mutations to improve activity, stability, specificity, or manufacturability.
However, mutations rarely behave independently.
A mutation that improves protein performance individually may become neutral—or even detrimental—when combined with other mutations.
Neoncorte Bio applies AI-driven epistasis prediction to identify beneficial mutation combinations and support more efficient protein engineering programs.